Zobrazeno 1 - 10
of 96
pro vyhledávání: '"V. Ryzhko"'
Autor:
A. M. Danilina, L. P. Mendeleeva, I. E. Kostina, E. O. Gribanova, V. V. Ryzhko, Ya. B. Bal'zhanova
Publikováno v:
Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, Vol 13, Iss 2, Pp 62-69 (2023)
Imaging of bone lesions has an important role in diagnosis of multiple myeloma (MM) and evaluating the response to treatment. Computed tomography scan (CT) allows to detect osteolysis, plasmacytoma and the risk of fractures with high sensitivity. In
Externí odkaz:
https://doaj.org/article/856d7e3004204ca0925d10ddcfddcd3d
Publikováno v:
Антибиотики и Химиотерапия, Vol 56, Iss 7-8, Pp 16-21 (2020)
Inducible character of resistance to tetracycline, chloramphenicol and ampicillin was investigated in 20 strains of Vibrio cholera non-O1/non-O139 serogroups isolated from inhabitants of Uzbekistan in 1990 (10 strains, ctx+) and in 2001 (5 strains, c
Externí odkaz:
https://doaj.org/article/42cbe9c59913411f99d99f873289528c
Autor:
N. A. Selyanskaya, I. V. Ryzhko, L. M. Verkina, A. V. Trishina, A. V. Mironova, M. V. Akulova
Publikováno v:
Антибиотики и Химиотерапия, Vol 56, Iss 1-2, Pp 18-21 (2020)
Analysis of the antibioticograms of the Vibrio cholerae non-O1/non-O139 strains showed that in the cultures isolated in the Rostov Region in 1968-1975 there were present markers of resistance to ampicillin (7%), kanamycin (15.8%), rifampicin (3.5%) a
Externí odkaz:
https://doaj.org/article/a89f8b8dae9f40f88ec72ef79538081e
Publikováno v:
Антибиотики и Химиотерапия, Vol 54, Iss 5-6, Pp 37-40 (2020)
Activity of levofloxacin, lomefloxacin and moxifloxacin against 20 FI+ and 20 FI- strains of Yersinia pestis was studied. It was shown that the strains were highly susceptible to the fluoroquinolones. In the experiments on mice subcutaneously infecte
Externí odkaz:
https://doaj.org/article/3d05ebd31efb4c93aa2b0a4087d5e4c8
Publikováno v:
Антибиотики и Химиотерапия, Vol 55, Iss 11-12, Pp 22-24 (2020)
The efficacy of levofloxacin and moxyfloxacin vs. the previously tested fluoroquinolones was studied on albino mice with experimental plague due to the Nalr mutants of Yersinia pestis 231 and 231 FI-. The plague microbe mutants resistant to nalidixic
Externí odkaz:
https://doaj.org/article/425677985c7048c9b173d9108188b938
Publikováno v:
Терапевтический архив, Vol 91, Iss 8, Pp 93-97 (2019)
Sorafenib has been used in acute myeloid leukemias with FLT3-ITD mutation improving the outcomes. However the high incidence of treatment - emergent adverse event may be associated with treatment using sorafenib with cytotoxic chemotherapy. We have r
Externí odkaz:
https://doaj.org/article/b9a1b8a086bc4b1b969dc76acafd6130
Publikováno v:
Онкогематология, Vol 13, Iss 3, Pp 63-75 (2018)
The aim of the study was to evaluate the profile and risk factors for acquisition of infections in patients with de novo multiple myeloma (MM) on the 1st chemotherapy cycle (CC).Materials and methods. Study included patients with de novo MM undergoin
Externí odkaz:
https://doaj.org/article/870c8b0718804491bfcdcb4a7f841cba
Autor:
V. V. Ryzhko, M. L. Kanaeva
Publikováno v:
Медицинский совет, Vol 0, Iss 14, Pp 94-102 (2017)
The use of proteasome inhibitors and immunomodulatory drugs in the clinical practice has contributed to the significant improvement in survival for patients with multiple myeloma over the past decades. Alongside this, due to the recurrent course of t
Externí odkaz:
https://doaj.org/article/6600ebee2cbb47b78959a49f58aa8893
Autor:
T V Abramova, T N Obukhova, L P Mendeleeva, O S Pokrovskaya, E O Gribanova, V V Ryzhko, L A Grebenyuk, M V Nareyko, M V Solovyev, O M Votyakova, S M Kulikov, M A Rusinov, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 89, Iss 7, Pp 32-38 (2017)
Aim. To determine the prevalence of amp1q21 and its relationship to the clinical manifestations of multiple myeloma (MM). Subjects and methods. In December 2009 to March 2016, a total 134 patients aged 30 to 81 years (median 57 years) underwent a pre
Externí odkaz:
https://doaj.org/article/7b4e34b526524669a31cc54969d8caac
Publikováno v:
Терапевтический архив, Vol 89, Iss 1, Pp 72-77 (2017)
Concurrences of multiple myeloma with myeloproliferative diseases or secondary myeloid leukemoid reactions are rather rare. The paper describes 3 cases of multiple myeloma: the first case concurrent with neutrophilic leukocytosis; the second case wit
Externí odkaz:
https://doaj.org/article/9c81637a26874f5196d880a3274690e3